Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2011
06/01/2011CN102078406A Traditional Chinese medicine for treating insomnia
06/01/2011CN102078397A Traditional Chinese medicine compound and preparation method thereof
06/01/2011CN102078383A Compound ginkgo leaf capsule and tablet preparation method
06/01/2011CN102078381A Medicament to prevent and treat neurasthenia and preparation method thereof
06/01/2011CN102078369A Application of Chinese patent drug for treating peptic ulcer in preparing alcohol resistance medicament
06/01/2011CN102078358A Application of chrysanthemum water extract in improving learning and memory
06/01/2011CN102078331A ICCB-containing compound preparation and preparation method thereof
06/01/2011CN102078330A Compound preparation containing in vitro cultivated calculus bovis (ICCB) and caffeine and preparation method thereof
06/01/2011CN102078327A Application of hydrogen sulfide donor to preparation of medicine for treating central nervous system disease
06/01/2011CN102078322A Medical purpose of piperacillin sodium/tazobactam sodium for injection
06/01/2011CN102078321A Blonanserin-containing medicinal composition and preparation method thereof
06/01/2011CN102078320A Iloperidone pharmaceutical composition and preparation method thereof
06/01/2011CN102078310A Generally linear effervescent oral fentanyl dosage form and methods of administering
06/01/2011CN102078309A Dispersible tablet containing antipsychotic medicines and application thereof
06/01/2011CN102078299A Citicoline sodium liposome solid preparation
06/01/2011CN102078288A Pediatric anesthesia induction oral administration formulation and preparation method thereof
06/01/2011CN102078028A Cigarette for benefiting gallbladder, reducing blood pressure and giving up smoking and preparation method thereof
06/01/2011CN101816751B Medicament for treating epilepsy and tourette syndrome and preparation method thereof
06/01/2011CN101773632B Chinese medicine composition for treating dizziness and preparation method thereof
06/01/2011CN101745066B Medicine for treating senile dementia and preparation method thereof
06/01/2011CN101732458B Compound essential oil having functions of refreshing spirit, restoring consciousness and resisting fatigue, and wet tissue containing same
06/01/2011CN101559175B Compound decoction of divaricate saposhnikovia root and eucommia bark for treating headache
06/01/2011CN101544600B Method for separating and preparing ricinine
06/01/2011CN101537011B Pharmaceutical composition for preventing or treating parkinsonism and preparation method thereof
06/01/2011CN101530040B Essential plant fragrance smell area capable of improving depression symptoms and construction method thereof
06/01/2011CN101500998B Mono-and divalent salts of N-(5-hydroxynicotinoil)-L-glutaminic acid exhibiting psychotropic (antidepressant and anxyolytic), neuroprotective, heroprotective and cerebroprotective action
06/01/2011CN101433645B Chinese medicine preparation for resisting depression and stress-induced mental disorder, and preparation method thereof
06/01/2011CN101428080B Health care essential oil of magnolia flower
06/01/2011CN101323641B Anti-opioid peptide, antagonistic peptide thereof and use thereof
06/01/2011CN101248053B N-oxides as prodrugs of piperazine and piperidine derivatives
06/01/2011CN101229247B Medicine preparation for treating insomnia and preparing method thereof
06/01/2011CN101227917B Medicament with drug rehabilitation function and preparing method thereof
06/01/2011CN101189221B Ampa receptor potentiators
06/01/2011CN101129341B Intra-oral disintegration compositions and process for producing same
06/01/2011CN101076520B Imidazoline derivatives having cb1-antagonistic activity
05/2011
05/31/2011USRE42412 Materials and methods for the treatment of gastroesophageal reflux disease
05/31/2011US7951948 Spirocyclic cyclohexane compounds
05/31/2011US7951931 Nucleic acid encoding sodium channel SCN3A alpha subunits
05/31/2011US7951909 A polypeptide containing an N-terminal fragment of Amyloid beta (A beta ) peptide linked to a helper T cell epitope (Th) having multiple class II binding motifs; generated antibodies are highly cross-reactive to the soluble A beta 1-42 peptide and the amyloid plaques in the brain
05/31/2011US7951821 N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy
05/31/2011US7951820 Triazole compounds useful as protein kinase inhibitors
05/31/2011US7951811 Pyrrolo[2,3-D]pyrimidine derivatives substituted with a cyclic amino group
05/31/2011US7951810 Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of E1 activating enzymes
05/31/2011US7951798 Polymorphs of olanzapine hydrochloride
05/31/2011US7951797 Substituted diazepan orexin receptor antagonists
05/31/2011US7951795 Constrained spirocyclic compounds as CGRP receptor antagonists
05/31/2011US7951371 Soluble lymphotoxin-β receptor fusion protein and methods for inhibiting lymphotoxin β-receptor signaling
05/31/2011CA2601716C Methods and compositions for the treatment of attention deficit hyperactivity disorder and hyperphenylalanemia
05/31/2011CA2517493C Therapeutic patch with polysiloxane matrix comprising capsaicin
05/31/2011CA2497450C Pyrazolopyrimidines as cyclin dependent kinase inhibitors
05/31/2011CA2475764C New inhibitors of histone deacetylase
05/31/2011CA2465750C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]-indole-1-carboxamide derivatives, their preparation and therapeutic use
05/31/2011CA2455635C Use of thiazole derivatives for preparing a medicine for protecting mitochondria
05/31/2011CA2438661C Yeast screens for agents affecting protein folding
05/31/2011CA2398929C Neuroprotective, antithrombotic and anti-flammatory uses of activated protein c (apc)
05/31/2011CA2369725C Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
05/26/2011WO2011063415A2 Methods for treating mild cognitive impairment
05/26/2011WO2011063272A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use
05/26/2011WO2011063233A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use
05/26/2011WO2011063178A2 Intravenous infusion of curcumin and a calcium channel blocker
05/26/2011WO2011063164A2 Sustained release cannabinoid medicaments
05/26/2011WO2011063115A1 Combination of nootropic agent with one or more neurogenic or neurogenic sensitizing agents for stimulating or increasing neurogenesis
05/26/2011WO2011062864A2 Inhibitors of nox enzymes and methods of use thereof
05/26/2011WO2011062777A1 Methods and compositions for the treatment of psychotic disorders through the identification of the sult4a1-1 haplotype
05/26/2011WO2011062550A1 Benzoimidazole compounds and uses thereof
05/26/2011WO2011062284A1 A cycloalkane derivative
05/26/2011WO2011062253A1 Novel fused pyrimidine derivative
05/26/2011WO2011062194A1 Aminopyridine derivative
05/26/2011WO2011061754A1 A novel 3-substituted 7-imino-2-thioxo-3, 7-dihydro-2h-thiazolo [4,5-di pyrimidin-6-yl - and process for preparation thereof
05/26/2011WO2011061751A1 BICYCLIC COMPOUNDS AS α4β2 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
05/26/2011WO2011061744A2 Novel arylated camphenes, processes for their preparation and uses thereof
05/26/2011WO2011061469A1 Indazole derivatives and their use for blockading voltage dependent sodium channels
05/26/2011WO2011061332A1 Pharmaceutical composition comprising propofol
05/26/2011WO2011039388A3 3-indazolyl ether family with cannabinoid and/or cholinergic properties
05/26/2011WO2011039308A3 Gluten-free foodstuff
05/26/2011WO2011011692A3 Methods of treating and preventing/reducing the likelihood of mesial temporal lobe epilepsy (tle)
05/26/2011WO2011011330A3 Inhibitors of d-amino acid oxidase
05/26/2011WO2011006097A3 Methods For Treating Toxicity
05/26/2011WO2011005052A3 Novel arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same
05/26/2011WO2011003064A9 Methods of treating neuropathic pain
05/26/2011WO2010151755A3 TREATMENT OF INFLAMMATORY DISEASES USING miR-124
05/26/2011WO2010144711A3 Immunological targeting of pathological tau proteins
05/26/2011US20110124739 Use of Sphingosine-1-phosphate (S1P) Receptor Agonists for the Treatment of Brain Degenerative Diseases
05/26/2011US20110124735 Carbonylamino derivatives useful for the treatment of certain inflammatory disorders
05/26/2011US20110124731 Treatment Of Neurodegenerative Diseases And Cancer Of The Brain Using Histone Deacetylase Inhibitors
05/26/2011US20110124721 Methods of treating traumatic brain injury by administering baicalein preparation
05/26/2011US20110124712 Anti-cancer composition comprising microrna molecules
05/26/2011US20110124706 SOCS3 Inhibition Promotes CNS Neuron Regeneration
05/26/2011US20110124705 Prodrugs of alpha-2-delta ligands, pharmaceutical compositions and uses thereof
05/26/2011US20110124699 Method for treating nervous system disorders and conditions
05/26/2011US20110124690 Compositions and methods for treating cancer or a neurotrophic disorder
05/26/2011US20110124678 Treatment with alpha 7-selective ligands
05/26/2011US20110124676 Biaryl substituted azabicyclic alkane derivatives
05/26/2011US20110124673 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
05/26/2011US20110124672 Thienyl Compounds
05/26/2011US20110124671 Spiroindenes and spiroindanes as modulators of chemokine receptors
05/26/2011US20110124668 Novel indole derivative having, carbamoyl group, ureido group and substituted oxy group
05/26/2011US20110124666 3,4-dihydropyrimidine trpa1 antagonists
05/26/2011US20110124663 Substituted dioxopiperidines and dioxopyrrolidines as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
05/26/2011US20110124662 Substituted Carbamate Derivatives as Modulators of Corticotropin-Releasing Factor Receptor Activity